Singapore-born digital therapeutics company inks deal with Hong Kong govt to fight COVID-19
Wednesday, March 04, 2020
As the novel coronavirus (COVID-19) continues to spread, a Singapore born, Boston-based digital therapeutics company has inked a deal with The University of Hong Kong and Hong Kong's Department of Health to leverage its cutting-edge wearable technology and AI-powered remote monitoring platform to provide new insights to fight COVID-19 in a national disease monitoring program. This first-of-its-kind program-which has international implications and applications-points to the value of the emerging category of digital therapeutics in monitoring patients with diagnosed or suspected COVID-19, while also helping clinicians better understand the disease so that they can better treat it.
